Form 8-K - Current report:
SEC Accession No. 0001140361-25-027350
Filing Date
2025-07-25
Accepted
2025-07-25 16:43:19
Documents
15
Period of Report
2025-07-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ef20052589_8k.htm   iXBRL 8-K 35000
2 EXHIBIT 99.1 ef20052589_ex99-1.htm EX-99.1 9357
7 image00001.jpg GRAPHIC 2905
  Complete submission text file 0001140361-25-027350.txt   223923

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmy-20250721.xsd EX-101.SCH 4490
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20250721_def.xml EX-101.DEF 17940
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20250721_lab.xml EX-101.LAB 27063
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20250721_pre.xml EX-101.PRE 20182
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20052589_8k_htm.xml XML 7160
Mailing Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543
Business Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543 6092524621
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

EIN.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 251152140
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)